CGEM - Cullinan Oncology Inc Ordinary Shares (Healthcare: Biotechnology) Projected Earnings Date: 0000-02-29    (Delayed quote data   2025-07-11)
Last
 7.70		 Change
 ⇓ -0.10   (-1.28%)		 Volume
  235,839
Open
 7.75		 High
 7.83		 Low
 7.65
8EMA (Daily)
 7.68		 40EMA (Daily)
 8.02		 50EMA (Daily)
 8.09		 STO (Daily)
 28.114		 MACD Hist (Daily)
 -0.035
8EMA (Weekly)
 7.983		 40EMA (Weekly)
 10.25		 50EMA (Weekly)
 10.85		 STO (Weekly)
 42.120		 MACD Hist (Weekly)
 0.334
Company Profile
Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com